2003
DOI: 10.1128/jvi.77.1.237-244.2003
|View full text |Cite
|
Sign up to set email alerts
|

Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic

Abstract: Rabies virus (RV) vaccine strain-based vectors show great promise as vaccines against other viral diseases such as human immunodeficiency virus type 1 (HIV-1) infection and hepatitis C, but a low residual pathogenicity remains a concern for their use. Here we describe several highly attenuated second-generation RV-based vaccine vehicles expressing HIV-1 Gag. For this approach, we modified the previously described RV vaccine vector SPBN by replacing the arginine at position 333 (R333) within the RV glycoprotein… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
130
0

Year Published

2004
2004
2022
2022

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 91 publications
(133 citation statements)
references
References 33 publications
(50 reference statements)
3
130
0
Order By: Relevance
“…No such response was observed using an EHV-1 that expressed Gag from the authentic sequence, indicating that efficient priming of the immune system by recombinant EHV-1 vectors harboring foreign genes is possible. While direct comparisons, especially between different assays, are difficult, the number of Gag-specific CD8 ϩ cells reported using EHV-1 as a delivery vehicle appeared to be in the same range as that observed after vaccination using influenza viruses, poxviruses, or rhabdoviruses as the gene delivery vector (27,29,30,36), a more efficient response may be possible if various routes for primary and booster vaccinations are used, or if prime-boost regimens using DNA and virus formulations are applied. In addition, only a weak CD8-specific response was observed in animals that had been primed intranasally with H⌬gp2 virus and boosted twice with the Pr55 gag -expressing virus by the same route (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…No such response was observed using an EHV-1 that expressed Gag from the authentic sequence, indicating that efficient priming of the immune system by recombinant EHV-1 vectors harboring foreign genes is possible. While direct comparisons, especially between different assays, are difficult, the number of Gag-specific CD8 ϩ cells reported using EHV-1 as a delivery vehicle appeared to be in the same range as that observed after vaccination using influenza viruses, poxviruses, or rhabdoviruses as the gene delivery vector (27,29,30,36), a more efficient response may be possible if various routes for primary and booster vaccinations are used, or if prime-boost regimens using DNA and virus formulations are applied. In addition, only a weak CD8-specific response was observed in animals that had been primed intranasally with H⌬gp2 virus and boosted twice with the Pr55 gag -expressing virus by the same route (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…SPBN, a RABV vaccine strain-based vector, has been described previously (27). Vesicular stomatitis virus expressing green fluorescent protein (VSV-GFP) was obtained from John Hiscott (McGill University) (17).…”
Section: Methodsmentioning
confidence: 99%
“…The final plasmid was designated pCAGGs-4A. To construct the recombinant RV containing the respective M mutations the plasmids pCAGGs-35S, pCAGGs-36A, pCAGGs-38A, pCAGGs-41A, and pCAGGs-4A were digested with BstZ17I and SnaBI and the resulting fragment cloned into pSPBN (33). The resulting plasmids were designated pM35S, pM36A, pM38A, pM41A, and pM4A.…”
Section: Methodsmentioning
confidence: 99%